Description
JANVIA 50 is an oral medication used to manage type 2 diabetes mellitus. It contains Sitagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor that works by increasing the levels of incretin hormones. These hormones help regulate blood sugar by enhancing insulin release in response to meals and decreasing the amount of glucose produced by the liver. JANVIA 50 is typically prescribed as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It can be used alone or in combination with other antidiabetic medications.
.webp)
.jpeg)
.jpeg)
.webp)
.png)
.jpeg)
.png)
.webp)
.png)
Change Language